• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-TGFBI / BIGH3

TGFBI / BIGH3 Monoclonal Antibody for WB, IHC, IF-P, IP, ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain et plus (1)

Applications

WB, IHC, IF-P, IP, ELISA

Conjugaison

Non conjugué

Publications(9)

CloneNo.

3E11D11

N° de cat : 60007-1-Ig

Synonymes

TGFBI, 3E11D11, Beta ig h3, Beta ig-h3, BIGH3



Applications testées

Résultats positifs en WBtissu rénal humain,
Résultats positifs en IPcellules HeLa
Résultats positifs en IHCtissu de côlon humain, tissu de cancer de la peau humain, tissu de cancer du côlon humain, tissu placentaire humain, tissu rénal humain
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en IF-Ptissu de cancer du côlon humain,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunoprécipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochimie (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)-PIF-P : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

60007-1-Ig cible TGFBI / BIGH3 dans les applications de WB, IHC, IF-P, IP, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène TGFBI / BIGH3 Protéine recombinante Ag0241
Nom complet transforming growth factor, beta-induced, 68kDa
Masse moléculaire calculée 683 aa, 75 kDa
Poids moléculaire observé 68 kDa
Numéro d’acquisition GenBankBC000097
Symbole du gène TGFBI
Identification du gène (NCBI) 7045
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

TGFBI, also named as BIGH3, Kerato-epithelin and RGD-CAP, binds to type I, II, and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage, it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein, it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy, and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy.(PMID:20509890) Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).

Protocole

Product Specific Protocols
WB protocol for TGFBI / BIGH3 antibody 60007-1-IgDownload protocol
IHC protocol for TGFBI / BIGH3 antibody 60007-1-IgDownload protocol
IF protocol for TGFBI / BIGH3 antibody 60007-1-IgDownload protocol
IP protocol for TGFBI / BIGH3 antibody 60007-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
mouse,humanWB,IHC

Cancer Res

TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.

Authors - Laura S M Lecker
humanIF

Cell Rep

Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury

Authors - Yiheng Mao
humanWB,IHC

Int J Cancer

Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.

Authors - Ween Miranda P MP
humanWB

Cell Mol Life Sci

TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions.

Authors - Irigoyen M M
humanWB

Front Oncol

Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis.

Authors - Ya Wang
humanWB,IHC

Neoplasia

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.

Authors - Tianhong Pan
  • KD Validated
{{ptg:RelatedPrimaryAntibodies}}